Skip to main content

Table 2 Blood pressure/hemoglobin/glucose and Lipids profile, and Bone mineral density before/after treatment in the comparative groups

From: Weight loss therapy for clinical management of patients with some atherosclerotic diseases: a randomized clinical trial

Study groups

SBP, mmHg

DBP, mmHg

Hemoglobin, gram/L

Glucose, mmol/L

Cholesterol, mmol/L

Triglycerol, gram/L

BMD, Units

Conventional patient subgroup, n = 40

Before treatment

149.4 ± 3.4

94.8 ± 2.2

132.1 ± 2.2

6.40 ± 0.49

5.60 ± 0.1

2.15 ± 0.05

74.0 ± 2.9

After treatment

129.6 ± 3.5

93.1 ± 2.1

134.0 ± 2.4

5.27 ± 0.37

5.24 ± 0.16

1.92 ± 0.09

73.2 ± 1.6

Weight loss patient subgroup, n = 31

Before treatment

150.1 ± 3.9

99.3 ± 2.9

129.5 ± 2.67

6.42 ± 0.46

5.73 ± 0.13

2.31 ± 0.1

71.6 ± 2.79

After treatment

121.8 ± 2.1

81.6 ± 1.8

140.3 ± 1.6

4.37 ± 0.38

4.26 ± 0.15

1.62 ± 0.09

97.9 ± 2.8

P before and after treatment in Conventional patient subgroup =

<0.001

0.289

0.281

0.036

0.031

0.015

0.405

P before and after treatment in Weight loss patient subgroup =

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

  1. Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; BMD, bone mineral density
  2. Data are presented as Means ± SE